Smarter labs, faster results: The power of automation in drug discovery
Supported by:
19 June 2025
3:00pm
Shares
- Like
- Digg
- Del
- Tumblr
- VKontakte
- Buffer
- Love This
- Odnoklassniki
- Meneame
- Blogger
- Amazon
- Yahoo Mail
- Gmail
- AOL
- Newsvine
- HackerNews
- Evernote
- MySpace
- Mail.ru
- Viadeo
- Line
- Comments
- Yummly
- SMS
- Viber
- Telegram
- Subscribe
- Skype
- Facebook Messenger
- Kakao
- LiveJournal
- Yammer
- Edgar
- Fintel
- Mix
- Instapaper
- Copy Link
Join this expert-led webinar to discover how lab automation and AI are transforming early preclinical research. Learn how cutting-edge technologies are reshaping lab workflows, improving reproducibility, and fast-tracking drug development from discovery to preclinical validation.
The rapid evolution of lab automation is revolutionising early preclinical drug discovery, driving faster, more precise and cost-effective research outcomes. From liquid-handling robots to AI-powered data analytics, these technologies are streamlining workflows, minimising manual error and accelerating development timelines.
There are several core technologies and methods that are transforming lab automation. These tools strengthen lab automation, helping de-risk against failures and enabling reproducible and innovative processes. But they can be complex to understand for non-IT professionals. This webinar demystifies the topic.
Join Dr Raminderpal Singh, Global Head of AI & GenAI Practice at 20/15 Visioneers, for an exclusive look at how AI and automation are redefining the future of early preclinical research. Singh explores how technologies such as large language models, model-quality data, and FAIR data principles are enabling smarter, faster and more scalable approaches to drug discovery.
Why attend?
- Learn how AI can improve efficiency and accuracy in preclinical research
- Discover the value and power of model-quality data, FAIR and LLMs
- Gain the clarity and confidence to start planning for these tools and methods.
Who should attend?
- Lab scientists and researchers
- Lab equipment providers and technology vendors
- Lab managers, pharma leaders and R&D investors.
Don’t miss out – register now to stay updated on speakers, event details, and more >>>
SPEAKER
Dr Raminderpal Singh
Dr Raminderpal Singh is an advisory board member for Drug Target Review and a recognised key opinion leader in the techbio industry. He has over 30 years of global experience leading and advising teams on building computational modelling systems that are both cost-efficient and have significant IP value. His passion is to help early to mid-stage life sciences companies achieve novel biological breakthroughs through the effective use of computational modelling.
Raminderpal is currently leading the HitchhikersAI.org open-source community, accelerating the adoption of AI technologies in early drug discovery. He is also CEO and co-Founder of Incubate Bio – a techbio providing a service to life sciences companies who are looking to accelerate their research and lower their wet lab costs through in silico modelling.
Raminderpal has extensive experience building businesses in both Europe and the US. As a business executive at IBM Research in New York, Dr Singh led the go-to-market for IBM Watson Genomics Analytics. He was also Vice President and Head of the Microbiome Division at Eagle Genomics Ltd, in Cambridge. Raminderpal earned his PhD in semiconductor modelling in 1997. He has published several papers and two books and has twelve issued patents. In 2003, he was selected by EE Times as one of the top 13 most influential people in the semiconductor industry.
Key learning points
- Explore how AI and automation enhances efficiency and accuracy in drug discovery workflows
- Understand the challenges and best practices for integrating automation into preclinical research
- Gain insights into emerging lab automation technologies shaping the future of drug discovery
- Ask our expert speakers your questions and get industry-leading advice
FAQs
Is the webinar free?
Yes – there is no charge to watch the webinar, either live or on-demand.
When will the webinar take place?
The webinar will take place live on 19 June at 4:00 PM BST.
I’m busy. Can I watch it later?
The webinar will become available to watch on-demand shortly after the live webinar takes place.
What are the benefits of attending live?
During the live webinar, you’ll be able to ask the speakers your questions, which will then be answered during the live Q&A session towards the end of the webinar.
How long will the webinar be?
This webinar will last for up to one hour.
What do I need to watch this webinar?
All you need is a computer with an internet connection. Be sure to use headphones if in an office environment.
Do I receive a certificate?
Yes, you will receive a certificate if you attend the webinar live. The certificate will be sent with your on-demand video link.
